The Effect of Guideline Implementation Strategies on Akathisia Outcomes in Schizophrenia

Journal of Applied Research

Volumn 3, Issue 4, 2003, Pages 470-482

  Williams, D Keith ^a   Thrush, Carol R ^b   Armitage, Tracey L ^b   Owen, Richard R ^b   Hudson, Teresa J ^b   Thapa, Purushottham ^b  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b CENTRAL ARKANSAS VETERANS HEALTHCARE SYSTEM   (United States)

Author keywords

Akathisia; Clinical practice guidelines; Outcomes; Schizophrena; Statistics

Indexed keywords

NEUROLEPTIC AGENT; OLANZAPINE; RISPERIDONE;

ADULT; AKATHISIA; ANALYSIS OF VARIANCE; ARTICLE; BARNES AKATHISIA RATING SCALE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COVARIANCE; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTCOMES RESEARCH; PRACTICE GUIDELINE; PREVALENCE; RANDOMIZED CONTROLLED TRIAL; SCHIZOPHRENIA; SCORING SYSTEM;

EID: 2342660699     PISSN: 1537064X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Halstead SM, Barnes TRE, Speller JC. Akathisia: Prevalence and associated dysphoria in an in-patient population with chronic schizophrenia. Br J Psychiatry. 1994;164:177-183.
2. Brüne M, Sachdev PS. Ladislav Ha?kovec and 100 years of akathisia. Am J Psychiatry. 2002;159:727.
3. Lima AR, Weiser KV, Bacaltchuk J, Barnes TR. Anticholinergics for neuroleptic-induced acute akathisia. Cochrane Database Systematic Rev. 2002;(3):CD003727.
4. Halliday J, Farrington S, Macdonald S, MacEwan T, Sharkey V, McCreadie R. Nithsdale Schizophrenia Surveys 23: movement disorders. 20-year review. Br J Psychiatry. 2002;181:422-7
5. Schwartz TL, Saba M, Hardoby W, Virk S, Masand PS. Use of atypical antipsychotics in a Veterans Affairs Hospital. Prog Neuro-Psychopharmacol Biol Psychiatry. 2002;26:1207-1210.
6. Owen RR, Feng WW, Thrush CR, Hudson TJ, Austen MA. Variations in prescribing practices for novel antipsychotic medications among Veterans Affairs hospitals. Psychiatr Serv. 2001;52:1523-1525.
7. Hudson TJ, Owen RR, Thrush CR, Han X, Pyne J, Thapa P, Sullivan G. A pilot study of barriers to medication adherence in schizophrenia. J Clin Psychiatry. In press.
8. Barnes TRE. A rating scale for drug-induced akathisia. Br J Psychiatry. 1989;154:672-676.
9. Kay SR, Fiszbein A, Opler LA. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13:261-276.
10. Fischer EP, Cuffel BJ, Owen RR, et al. Schizophrenia outcomes module. Little Rock, AR University of Arkansas for Medical Sciences, 1996.
11. Cuffel BJ, Fischer EP, Owen RR, et al. An instrument for measurement of outcomes of care for schizophrenia: Issues in development and implementation. Eval Health Professions. 1997;20:96-108.
12. Cannon-Spoor HE, Potkin SG, Wyatt RJ. Measurement of premorbid adjustment in chronic schizophrenia. Schizophr Bull. 1982;8:470-484
13. Ewing JA. Detecting alcoholism: The CAGE questionnaire. JAMA. 1984;252:1905-1907.
14. Miklowitz DJ, Goldstein MJ, Nuechterlein KH, et al. Expressed emotion, affective style, Lithium compliance, and relapse in recent onset mania. Psychopharma Bull. 1986;22:628-632.
15. Miklowitz DJ, Goldstein MJ, Nuechterlein KH, et al. Family factors and the course of bipolar affective disorder. Arch Gen Psychiatry. 1988;45:225-231.
16. Conover J. Practical Nonparametric Statistics. New York, NY: John Wiley & Sons; 1980.
17. Brunner, E, Domhof, S & Langer, F. Nonparametric Analysis of Longitudinal Data in Factorial Experiments. New York: Wiley; 2002.
18. SAS Institute Inc. SAS/STAT User's Guide, Version 8. Cary, NC: SAS Institute Inc; 1999.
19. Rosenbaum, PR, Rubin, DB. The central role of the propensity score in observational studies for causal effects. Biometrika. 1983;70:41-55.
20. Lehman AF, Steinwachs DM. Translating research into practice: The Schizophrenia Patient Outcomes Research Team (PORT) treatment recommendations. Schizophr Bull. 1998;24:1-10.
21. Veterans Affairs, Mental Health Strategic Health Care Group, The Psychosis Working Group, Office of Performance and Quality. Veterans Health Administration clinical guideline for management of persons with psychoses. Washington, DC: Department of Veterans Affairs; 1997.
22. Lohr JB, Caligiuri M, Edson R, et al, VA Cooperative Study 394 Study Group. Treatment predictors of extrapyramidal side effects in patients with tardive dyskinesia: Results from Veterans Affairs Cooperative Study 394. J Clin Psychopharmacol. 2002;22:196-200.
23. Braude WM, Barnes TRE, Gore SM. Clinical characteristics of akathisia. A systematic investigation of acute psychiatric inpatient admissions. Br J Psychiatry. 1983;143:139-150.
24. Miller CH, Fleischhacker WW. Managing antipsychotic-induced acute and chronic akathisia. Drug Safety. 2000;22:73-81.